|
NBIX
|
Neurocrine Biosciences, Inc.
|
1.09%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
1.06%
|
US
|
NASDAQ
|
|
CRL
|
Charles River Laboratories International, Inc.
|
1.04%
|
US
|
NYSE
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
0.95%
|
US
|
NASDAQ
|
|
RGEN
|
Repligen Corporation
|
0.75%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
BRKR
|
Bruker Corporation
|
0.63%
|
US
|
NASDAQ
|
|
LEGN
|
Legend Biotech Corporation
|
0.57%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
0.53%
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
0.51%
|
US
|
NASDAQ
|
|
ASND
|
Ascendis Pharma A/S
|
0.50%
|
US
|
NASDAQ
|
|
MEDP
|
Medpace Holdings, Inc.
|
0.47%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.43%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
0.41%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
RXDX
|
Prometheus Biosciences, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
0.36%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.36%
|
US
|
NASDAQ
|
|
SYNH
|
Syneos Health, Inc.
|
0.34%
|
US
|
NASDAQ
|